Personalized medicine is here. But it’s up to insurance carriers to catch up with technology that’s hurtling forward faster and faster, or so says Manuel Glynias, CEO of Cleveland-based GenomOncology, His company is in the business of solving how doctors can use genomic data to treat cancer, the first major frontier in the application of personalized medicine. It’s difficult to parse the […]
A bioinformatics company that’s developed software to analyze sequenced genomic data from cancer patients and their tumors has received a $250,000 investment from nonprofit business development group JumpStart. Cleveland-area GenomOncology had previously raised $1.25 million, MedCity News reported late last month. GenomOncology labels itself as a “genomics-as-a-service” business. The company predicts that the key to […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
A new approach to review the genetic makeup of cancer patients and their tumors could enable customized cancer treatments. It’s been too hard for scientists to analyze peoples’ genetic data. Figuring out the details behind a genome can take weeks and cost up to $100,000. But GenomOncology, based in Cleveland, Ohio, says its mix of […]